Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology 2025-10-22 14:00
WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index 2025-10-22 08:30
Charming Medical Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq 2025-10-21 23:00
HanchorBio Secures US Patent for Innovative SIRPα/CD47 Fusion Protein HCB101 2025-10-21 19:00
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy 2025-10-21 10:49
SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform 2025-10-21 09:20
WellsCare Partners with Celltrion Canada to Bring Advanced Wearable Pain Relief Tech to North America 2025-10-20 21:00
Exploring the Next Era of Cell & Gene Therapy with Nobel Laureate in London 2025-10-20 19:43
HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025 2025-10-20 19:00
Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington's Disease Treatment 2025-10-20 18:13
Live from ESMO | Hengrui Debuts Exhibition Booth with Landmark Data Showcasing Pharma's Emerging Innovation Power 2025-10-20 14:20
CARsgen Presents Preliminary Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025 2025-10-20 08:15
ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody) 2025-10-20 08:10
Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances 2025-10-20 07:00
Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025 2025-10-19 23:42
HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet 2025-10-19 23:37
United Imaging Marks Five Years Since the Opening of its Global Showroom In North America with a Record Number of U.S. Customer Visits 2025-10-19 22:00
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia 2025-10-19 14:00
Multitude Therapeutics Announces Promising Interim Phase I/II Results from the Ongoing First-in-Human Study Evaluating its CD44v9-directed Antibody-Drug-Conjugate, AMT-116, in Heavily Pretreated EGFR Wild-type Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 2025-10-17 22:00
FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States 2025-10-17 13:32
1 8 9 10 11 12 491